Loading...
11 North America OB/GYN Drugs Reports
Region Covered: North America
Study Period: 2021 - 2029
Countries Covered: United States, Canada, Mexico, Germany, United Kingdom, France, Italy, Spain, China, Japan, India, Australia, South Korea, South Africa, Brazil, Argentina
Major Players: Teva Pharmaceuticals, Bayer AG, Pfizer Inc., Amneal Pharmaceuticals LLC, Mayne Pharma
Region Covered: North America
Study Period: 2019 - 2029
Countries Covered: United States, Canada, Mexico, Germany, United Kingdom, France, Italy, Spain, China, Japan, India, Australia, South Korea, South Africa, Brazil, Argentina
Major Players: Melinta Therapeutics Inc., Merck & Co. Inc., Pfizer Inc., GlaxoSmithKline, Cipla Inc.
Region Covered: North America
Study Period: 2019 - 2029
Countries Covered: United States, Canada, Mexico, France, Germany, United Kingdom, Italy, Spain, China, Japan, India, Australia, South Korea, South Africa, Brazil, Argentina
Major Players: Pfizer Inc., Teva Pharmaceutical Industries Limited, Novartis International AG, Takeda Pharmaceutical Company Limited, Bayer AG
Region Covered: North America
Study Period: 2019 - 2029
Countries Covered: United States, Canada, Mexico, Germany, United Kingdom, France, Italy, Spain, China, Japan, India, Australia, South Korea, South Africa, Brazil, Argentina
Major Players: Novartis AG, Bayer AG, Abbott Laboratories, F. Hoffmann-La Roche Ltd, Sanofi
Region Covered: North America
Study Period: 2019 - 2029
Countries Covered: United States, Canada, Mexico, Germany, United Kingdom, France, Italy, Spain, China, Japan, India, Australia, South Korea, South Africa, Brazil, Argentina
Major Players: Ferring Holding SA, TherapeuticsMD Inc., AbbVie Inc., Pfizer Inc., GSK plc
Region Covered: North America
Study Period: 2021 - 2029
Countries Covered: United States, Canada, Mexico, Germany, United Kingdom, France, Italy, Spain, China, Japan, India, Australia, South Korea, South Africa, Brazil, Argentina
Major Players: Bayer AG, Novartis AG, Pfizer, Inc, Novo Nordisk Corporation, AbbVie Inc.(Allergan Plc)
Region Covered: North America
Study Period: 2019 - 2029
Countries Covered: United States, Canada, Mexico, Germany, United Kingdom, France, Italy, Spain, China, Japan, India, Australia, South Korea
Major Players: Eli Lilly and Company, GlaxoSmithKline Plc, H. Lundbeck A/S , MetP Pharma AG , Bayer AG
Region Covered: North America
Study Period: 2019 - 2029
Countries Covered: United States, Canada, Mexico, Germany, United Kingdom, France, Italy, Spain, China, Japan, India, Australia, South Korea, South Africa, Brazil, Argentina
Major Players: Upsher-Smith Laboratories, Viatris Inc., Cadila Pharmaceuticals, Bayer AG, Stada Arzneimittel AG
Region Covered: North America
Study Period: 2019 - 2029
Countries Covered: United States, Canada, Mexico, Germany, United Kingdom, France, Italy, Spain, China, Japan, India, Australia, South Korea, South Africa, Brazil, Argentina
Major Players: Bayer AG, Pfizer Inc., AbbVie Inc. , Lannett, Teva Pharmaceutical Industries
Region Covered: North America
Study Period: 2019 - 2029
Countries Covered: United States, Canada, Mexico, Germany, United Kingdom, France, Italy, Spain, China, Japan, India, Australia, South Korea, South Africa, Brazil, Argentina
Major Players: Amgen Inc. , Eli Lilly and Co. , F. Hoffmann-La Roche Ltd , Merck & Co., Inc. , Allergan plc
Region Covered: North America
Study Period: 2019 - 2029
Countries Covered: United States, Canada, Mexico, Germany, United Kingdom, France, Italy, Spain, China, Japan, India, Australia, South Korea, South Africa, Brazil, Argentina
Major Players: Gynesonics, Medtronic, INSIGHTEC, Myovant Sciences GmbH, Boston Scientific Corporation
Filter Reports
By Countries
